Wells Fargo & Company MN Increases Position in Akebia Therapeutics, Inc. (NASDAQ:AKBA)
Wells Fargo & Company MN increased its position in Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) by 23.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 122,397 shares of the biopharmaceutical company’s stock after acquiring an additional 23,099 shares during the period. […]
Wells Fargo & Company MN increased its position in Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) by 23.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 122,397 shares of the biopharmaceutical company’s stock after acquiring an additional 23,099 shares during the period. […]
